Vertical Peak Holdings Inc (SPLIF)
0.004
0.00 (0.00%)
USD |
OTCM |
May 06, 16:00
Vertical Peak Holdings Cash from Operations (TTM): -0.632M for April 30, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
April 30, 2023 | -0.632M |
January 31, 2023 | -0.9068M |
October 31, 2022 | -1.299M |
July 31, 2022 | -1.376M |
April 30, 2022 | -2.829M |
January 31, 2022 | -2.459M |
October 31, 2021 | -2.429M |
July 31, 2021 | -1.888M |
April 30, 2021 | -1.998M |
January 31, 2021 | -0.7258M |
October 31, 2020 | -0.9972M |
July 31, 2020 | -1.499M |
April 30, 2020 | -2.780M |
January 31, 2020 | -4.989M |
October 31, 2019 | -7.761M |
July 31, 2019 | -9.152M |
April 30, 2019 | -6.229M |
January 31, 2019 | -7.317M |
October 31, 2018 | -5.309M |
July 31, 2018 | -4.189M |
April 30, 2018 | -5.260M |
January 31, 2018 | -3.210M |
October 31, 2017 | -2.322M |
July 31, 2017 | -2.303M |
April 30, 2017 | -1.105M |
Date | Value |
---|---|
January 31, 2017 | -1.352M |
October 31, 2016 | -1.075M |
July 31, 2016 | -0.5052M |
April 30, 2016 | -0.6753M |
January 31, 2016 | -1.118M |
October 31, 2015 | -1.069M |
July 31, 2015 | -1.343M |
April 30, 2015 | -1.514M |
January 31, 2015 | -0.66M |
October 31, 2014 | -0.598M |
July 31, 2014 | -0.3639M |
April 30, 2014 | 0.00 |
January 31, 2014 | 0.00 |
October 31, 2013 | 0.00 |
July 31, 2013 | 0.00 |
April 30, 2013 | |
January 31, 2013 | |
October 31, 2012 | |
July 31, 2012 | |
April 30, 2012 | |
January 31, 2012 | |
July 31, 2010 | -0.0212M |
April 30, 2010 | -0.0023M |
January 31, 2010 | -0.0097M |
October 31, 2009 | -0.0097M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-9.152M
Minimum
Jul 2019
-0.632M
Maximum
Apr 2023
-2.732M
Average
-1.943M
Median
Cash from Operations (TTM) Benchmarks
Acasti Pharma Inc | -13.57M |
Aurinia Pharmaceuticals Inc | -33.46M |
Edesa Biotech Inc | -6.252M |
Lexaria Bioscience Corp | -5.209M |
Xenon Pharmaceuticals Inc | -145.33M |